معرفی
Dr Andrea Cherrington serves as a Trial Manager at Keele University's School of Medicine, where she has worked since July 2014 following her PhD completion at the University of Manchester in 2009. Her research bridges cardiovascular disease, mental health, and musculoskeletal conditions, with recent focus on osteoporosis and osteoarthritis management through major clinical trials.
Education:
- PhD in health research from University of Manchester (2009), investigating depression's impact on quality of life in coronary heart disease patients
Dr Cherrington's work centers on patient-centered interventions for chronic conditions, particularly examining psychological factors in cardiovascular disease and developing shared decision-making frameworks for musculoskeletal disorders. Her methodology expertise spans pragmatic clinical trials, economic evaluations, and mixed-methods process assessments, consistently addressing implementation challenges in real-world healthcare settings.
Analysis of her 2023-2025 publications reveals a cohesive research trajectory focused on the iFraP trial ecosystem, integrating clinical protocols, process evaluations, and economic analyses to optimize osteoporosis treatment uptake. This work demonstrates methodological sophistication across health economics, digital health interventions, and qualitative implementation science.
Research Leadership: She actively contributes to Keele's Applied Research Collaboration and National Institute for Health Research initiatives, managing complex trials like iFraP that involve multidisciplinary teams across primary care, fracture liaison services, and academic institutions. Her current projects emphasize translating evidence into practice through computerized decision support and patient-centered consultation models.
